HHS contracts with Mapp Biopharmaceutical to develop Ebola drug
The development of a medication to treat illness from Ebola will be accelerated under a contract with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR). This contract supports the government-wide response to the Ebola outbreak in West Africa.
Read more about today's announcement.
Read more about today's announcement.
No hay comentarios:
Publicar un comentario